BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3034406)

  • 1. Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.
    Nelson WG; Cho KR; Hsiang YH; Liu LF; Coffey DS
    Cancer Res; 1987 Jun; 47(12):3246-50. PubMed ID: 3034406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural aspects of mammalian DNA replication: topoisomerase II.
    Nelson WG; Coffey DS
    NCI Monogr; 1987; (4):23-9. PubMed ID: 2819726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM; Culp DA
    Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-fat diet does not influence the growth of the Dunning R3327-H transplantable prostate adenocarcinoma.
    Schwab ED; Normolle D; Pacis RA; Cho SS; Pienta KJ
    Anticancer Res; 1998; 18(5A):3603-7. PubMed ID: 9858946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.
    Rubenstein M; Shaw MW; McKiel CF; Ray PS; Guinan PD
    Cancer Res; 1987 Jan; 47(1):178-82. PubMed ID: 3491674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma.
    Hall M; Silverman L; Wenger AS; Mickey DD
    Cancer Res; 1985 Sep; 45(9):4053-9. PubMed ID: 2992772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
    Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
    Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A; Block NL; Stover BJ; Irvin GL
    Cancer Res; 1985 Mar; 45(3):1052-7. PubMed ID: 3971360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
    Powell CT; Fair WR; Heston WD
    Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin filament organization of the Dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential.
    Zachary JM; Cleveland G; Kwock L; Lawrence T; Weissman RM; Nabell L; Fried FA; Staab EV; Risinger MA; Lin S
    Cancer Res; 1986 Feb; 46(2):926-32. PubMed ID: 3940653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma.
    Hughes C; Murphy A; Martin C; Fox E; Ring M; Sheils O; Loftus B; O'Leary J
    J Clin Pathol; 2006 Jul; 59(7):721-4. PubMed ID: 16556661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
    Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
    Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound.
    Huber PE; Pfisterer P
    Gene Ther; 2000 Sep; 7(17):1516-25. PubMed ID: 11001372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
    Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS
    Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
    Dibner JJ; Nakeff A
    J Natl Cancer Inst; 1983 Jun; 70(6):1057-66. PubMed ID: 6574275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
    Husain I; Mohler JL; Seigler HF; Besterman JM
    Cancer Res; 1994 Jan; 54(2):539-46. PubMed ID: 8275492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.